The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Lilly; MSD Oncology; Novartis; Pfizer; Takeda
Speakers' Bureau - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Foundation Medicine; MSD Oncology; Pfizer; Roche; Takeda
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - MSD Oncology; Roche; Takeda
 
(OPTIONAL) Uncompensated Relationships - Achilles Therapeutics
An open-label, multicenter phase I/IIa study evaluating the safety and clinical activity of clonal neoantigen reactive T cells in patients with advanced non-small cell lung cancer (CHIRON).
 
Mariam Jamal-Hanjani
No Relationships to Disclose
 
Alastair Greystoke
No Relationships to Disclose
 
Fiona Thistlethwaite
Honoraria - Bayer
Consulting or Advisory Role - Achilles Therapeutics; Bristol-Myers Squibb; Evelo Therapeutics; GlaxoSmithKline; Octimet (Inst); T-Knife; Zelluna
Research Funding - 3-V Biosciences (Inst); Abbvie (Inst); Actuate Therapeutics (Inst); Adaptimmune (Inst); Adaptimmune (Inst); Agalimmune (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); BerGenBio (Inst); Blueprint Medicines (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Carrick Therapeutics (Inst); CytomX Therapeutics (Inst); Eisai (Inst); GenMab (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Immutep (Inst); Incyte (Inst); Janssen (Inst); kinex (Inst); Lilly (Inst); Macrogenics (Inst); MedImmune (Inst); Merck (Inst); Millenium Pharamceuticals (Inst); MSD (Inst); Novartis (Inst); Octimet (Inst); Orion (Inst); Pfizer (Inst); Redx Pharma (Inst); Roche (Inst); Roche (Inst); Sierra Oncology (Inst); Synthon (Inst); Takeda (Inst); Tarveda Therapeutics (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Zelluna
Other Relationship - iMatch
 
Yvonne J. Summers
No Relationships to Disclose
 
Jennifer Allison
Honoraria - Bristol-Myers Squibb
Travel, Accommodations, Expenses - EUSA Pharma
 
Judith Cave
Travel, Accommodations, Expenses - Amgen; Roche
 
Kim Orchard
Stock and Other Ownership Interests - GlaxoSmithKline
Honoraria - Astellas Oncology
Patents, Royalties, Other Intellectual Property - Personal IP in radioimmuntherapy
 
Christian Ottensmeier
Stock and Other Ownership Interests - NEUVOGEN
Honoraria - Delcath Systems; Transgene
Consulting or Advisory Role - Bristol-Myers Squibb; Delcath Systems; Merck Sharp & Dohme; NEUVOGEN
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme
Research Funding - BioNTech (Inst); Bristol-Myers Squibb (Inst); Delcath Systems (Inst); Merck Sharp & Dohme (Inst); PsiOxus Therapeutics (Inst); Touchlight Genetics (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Delcath Systems
Other Relationship - Transgene
 
Gary Middleton
No Relationships to Disclose
 
Leila Khoja
No Relationships to Disclose
 
Michael Grant
Employment - Achilles Therapeutics
Stock and Other Ownership Interests - Achilles Therapeutics
Honoraria - MSD
 
Shreenal Patel
Employment - Achilles Therapeutics
Stock and Other Ownership Interests - Achilles Therapeutics
 
Jane Robertson
Employment - Achilles Therapeutics
Stock and Other Ownership Interests - Achilles Therapeutics
 
Karl Peggs
Employment - Achilles Therapeutics
Leadership - Achilles Therapeutics
Stock and Other Ownership Interests - Achilles Therapeutics
Honoraria - Autolus; Gilead Sciences; Merck Sharp & Dohme; Takeda
Consulting or Advisory Role - Autolus; Cytoseek; Gilead Sciences; Takeda
Speakers' Bureau - Gilead Sciences; Merck Sharp & Dohme
Patents, Royalties, Other Intellectual Property - Achilles Therapeutics
Travel, Accommodations, Expenses - Takeda
 
Martin Forster
Consulting or Advisory Role - Achilles Therapeutics; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Guardant Health; Lilly; Merck Sharp & Dohme; Nanobiotix; Novartis; Oxford VacMedix; Pfizer; PharmaMar; Roche; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Merck Serono (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Celgene; Guardant Health; MSD Oncology; Roche